Literature DB >> 26046094

A variant of FGF19 for treatment of disorders of cholestasis and bile acid metabolism.

Julian R F Walters1, Richard N Appleby1.   

Abstract

Entities:  

Year:  2015        PMID： 26046094      PMCID： PMC4437929          DOI： 10.3978/j.issn.2305-5839.2015.03.38

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  23 in total

1.  The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.

Authors:  Serge J L B Zweers; Klaske A C Booij; Mina Komuta; Tania Roskams; Dirk J Gouma; Peter L M Jansen; Frank G Schaap
Journal:  Hepatology       Date:  2011-12-19       Impact factor: 17.425

2.  Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

Authors:  T Lundåsen; C Gälman; B Angelin; M Rudling
Journal:  J Intern Med       Date:  2006-12       Impact factor: 8.989

3.  Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.

Authors:  Hiroshi Kurosu; Mihwa Choi; Yasushi Ogawa; Addie S Dickson; Regina Goetz; Anna V Eliseenkova; Moosa Mohammadi; Kevin P Rosenblatt; Steven A Kliewer; Makoto Kuro-o
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

Review 4.  FGF19 and cancer.

Authors:  Benjamin C Lin; Luc R Desnoyers
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

5.  Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice.

Authors:  Iker Uriarte; Maite G Fernandez-Barrena; Maria J Monte; Maria U Latasa; Haisul C Y Chang; Simone Carotti; Umberto Vespasiani-Gentilucci; Sergio Morini; Eva Vicente; Axel R Concepcion; Juan F Medina; José Juan G Marin; Carmen Berasain; Jesus Prieto; Matías A Avila
Journal:  Gut       Date:  2013-01-03       Impact factor: 23.059

6.  Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma.

Authors:  Jiyeon Hyeon; Soomin Ahn; Jae Jun Lee; Dae Hyun Song; Cheol-Keun Park
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

7.  A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.

Authors:  Julian R F Walters; Ali M Tasleem; Omer S Omer; W Gordon Brydon; Tracy Dew; Carel W le Roux
Journal:  Clin Gastroenterol Hepatol       Date:  2009-05-06       Impact factor: 11.382

8.  A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.

Authors:  Katrina Nicholes; Susan Guillet; Elizabeth Tomlinson; Kenneth Hillan; Barbara Wright; Gretchen D Frantz; Thinh A Pham; Lisa Dillard-Telm; Siao Ping Tsai; Jean-Philippe Stephan; Jeremy Stinson; Timothy Stewart; Dorothy M French
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

9.  Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test.

Authors:  D Stejskal; M Karpísek; Z Hanulová; P Stejskal
Journal:  Scand J Clin Lab Invest       Date:  2008       Impact factor: 1.713

10.  FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.

Authors:  Serkan Kir; Sara A Beddow; Varman T Samuel; Paul Miller; Stephen F Previs; Kelly Suino-Powell; H Eric Xu; Gerald I Shulman; Steven A Kliewer; David J Mangelsdorf
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728
View more
  4 in total

1.  No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.

Authors:  Gustavo Villalona; Amber Price; Keith Blomenkamp; Chandrashekhara Manithody; Saurabh Saxena; Thomas Ratchford; Matthew Westrich; Vindhya Kakarla; Shruthika Pochampally; William Phillips; Nicole Heafner; Niraja Korremla; Jose Greenspon; Miguel A Guzman; Ajay Kumar Jain
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-04-27       Impact factor: 4.016

Review 2.  Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.

Authors:  Claudia D Fuchs; Michael Trauner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-02-14       Impact factor: 73.082

3.  Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study.

Authors:  Tomas Koller; Martina Galambosova; Simona Filakovska; Michaela Kubincova; Tibor Hlavaty; Jozef Toth; Anna Krajcovicova; Juraj Payer
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

4.  Soluble Expression of hFGF19 without Fusion Protein through Synonymous Codon Substitutions and DsbC Co-Expression in E. coli.

Authors:  Hye-Ji Choi; Dae-Eun Cheong; Su-Kyoung Yoo; Jaehong Park; Dong-Hyun Lee; Geun-Joong Kim
Journal:  Microorganisms       Date:  2020-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.